Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Clinical trial NCT02126358 · COMPLETED

Trial details

NCT number: NCT02126358
Sponsor: LG Life Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Dyslipidemia

Start date: 2014-05-01
Primary completion: 2016-03-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.